Application of Piezo-Based Measuring System for Evaluation of Nucleic Acid-Based Drugs Influencing the Coagulation

During open-heart surgery, the status of hemostasis has to be constantly monitored to quickly and reliably detect bleeding or coagulation disorders. In this study, a novel optimized piezo-based measuring system (PIEZ) for rheological monitoring of hemostasis was established. The applicability of the PIEZ for the evaluation of nucleic acid-based drugs influencing coagulation was analyzed. Thrombin aptamers such as NU172 might be used during extracorporeal circulation (ECC) in combination with a reduced heparin concentration or for patients with heparin-induced thrombocytopenia (HIT). Therefore, the effect of the coagulation inhibiting thrombin aptamer NU172 and the abrogation by its complementary antidote sequence (AD) were investigated by this rheological PIEZ system. After the addition of different NU172 concentrations, the coagulation of fresh human blood was analyzed under static conditions and using an in vitro rotation model under dynamic conditions (simulating ECC). The clotting times (CTs) detected by PIEZ were compared to those obtained with a medical reference device, a ball coagulometer. Additionally, after the circulation of blood samples for 30 min at 37 °C, blood cell numbers, thrombin markers (thrombin-antithrombin III (TAT) and fibrinopeptide A (FPA)) and a platelet activation marker (β-thromboglobulin (β-TG)) were analyzed by enzyme-linked immunosorbent assays (ELISAs). The increase of NU172 concentration resulted in prolonged CTs, which were comparable between the reference ball coagulometer and the PIEZ, demonstrating the reliability of the new measuring system. Moreover, by looking at the slope of the linear regression of the viscous and elastic components, PIEZ also could provide information on the kinetics of the coagulation reaction. The shear viscosity at the end of the measurements (after 300 s) was indicative of clot firmness. Furthermore, the PIEZ was able to detect the abrogation of coagulation inhibition after the equimolar addition of NU172 aptamer´s AD. The obtained results showed that the established PIEZ is capable to dynamically measure the hemostasis status in whole blood and can be applied to analyze nucleic acid-based drugs influencing the coagulation.

[1]  Nicole Rauch,et al.  Dynamic and Quantitative Assessment of Blood Coagulation Status with an Oscillatory Rheometer , 2018 .

[2]  S. Fennrich,et al.  Hemocompatibility testing according to ISO 10993-4: discrimination between pyrogen- and device-induced hemostatic activation. , 2014, Materials science & engineering. C, Materials for biological applications.

[3]  P. Reitsma,et al.  New fundamentals in hemostasis. , 2013, Physiological reviews.

[4]  P. Williams,et al.  Studies of whole blood coagulation by oscillatory shear, thromboelastography and free oscillation rheometry. , 2008, Clinical hemorheology and microcirculation.

[5]  Min Wu,et al.  Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy , 2015, Theranostics.

[6]  B. Sullenger,et al.  A high affinity, antidote‐controllable prothrombin and thrombin‐binding RNA aptamer inhibits thrombin generation and thrombin activity , 2012, Journal of thrombosis and haemostasis : JTH.

[7]  B. Sullenger,et al.  Potent Anticoagulant Aptamer Directed against Factor IXa Blocks Macromolecular Substrate Interaction* , 2012, The Journal of Biological Chemistry.

[8]  Rapid Complexation of Aptamers by Their Specific Antidotes , 2017, Molecules.

[9]  Markandey M. Tripathi,et al.  Assessing blood coagulation status with laser speckle rheology. , 2014, Biomedical optics express.

[10]  M. Mackley,et al.  The rheological characterization of linear viscoelasticity for ink jet fluids using piezo axial vibrator and torsion resonator rheometers , 2010 .

[11]  J. Crassous,et al.  Characterization of the viscoelastic behavior of complex fluids using the piezoelastic axial vibrator , 2005 .

[12]  G. Mayer,et al.  Aptamer-based modulation of blood coagulation , 2011, Hämostaseologie.

[13]  P. Punjabi,et al.  The science and practice of cardiopulmonary bypass: From cross circulation to ECMO and SIRS , 2013, Global cardiology science & practice.

[14]  M. Seeberger,et al.  Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. , 2012, Transfusion medicine reviews.

[15]  Claus-Dieter Ohl,et al.  Red blood cell rheology using single controlled laser-induced cavitation bubbles. , 2011, Lab on a chip.

[16]  U. Schött,et al.  Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates , 2013, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

[17]  B. Sullenger,et al.  RNA aptamers as reversible antagonists of coagulation factor IXa , 2002, Nature.

[18]  R. Stoltenburg,et al.  SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands. , 2007, Biomolecular engineering.

[19]  Madoka Suzuki,et al.  Fast temperature measurement following single laser-induced cavitation inside a microfluidic gap , 2014, Scientific Reports.

[20]  S. Krauss,et al.  Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation. , 2014, Thrombosis research.

[21]  M. Blombäck,et al.  Measurement of blood and plasma coagulation time using free oscillating rheometry , 2002, Scandinavian journal of clinical and laboratory investigation.

[22]  George Quick,et al.  Antidote-mediated control of an anticoagulant aptamer in vivo , 2004, Nature Biotechnology.

[23]  J. Herbert,et al.  Investigation of the selectivity of thrombin-binding aptamers for thrombin titration in murine plasma. , 2016, Biosensors & bioelectronics.

[24]  M. Besser,et al.  The place of viscoelastic testing in clinical practice , 2016, British journal of haematology.

[25]  J. Dinardo,et al.  TEG and ROTEM: Technology and clinical applications , 2014, American journal of hematology.

[26]  M. Blombäck,et al.  Clotting Onset Time May Be a Predictor of Outcome in Human Brain Injury: A Pilot Study , 2003, Journal of Neurosurgical Anesthesiology.

[27]  C. Kahn,et al.  An Urban 9-1-1 System’s Experience with Left Ventricular Assist Device Patients , 2018, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[28]  K. Zacharowski,et al.  Effects of cardiac surgery on hemostasis. , 2006, Transfusion medicine reviews.

[29]  M. Avci-Adali,et al.  Blood-Contacting Biomaterials: In Vitro Evaluation of the Hemocompatibility , 2018, Front. Bioeng. Biotechnol..

[30]  T. Warkentin.  Heparin‐induced thrombocytopenia‐associated thrombosis: from arterial to venous to venous limb gangrene , 2018, Journal of thrombosis and haemostasis : JTH.

[31]  M. Borggrefe,et al.  Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[32]  U. Steinseifer,et al.  First In Vivo Results of a Novel Pediatric Oxygenator with an Integrated Pulsatile Pump , 2015, ASAIO journal.